Cimzia and Hepatitis acute - a phase IV clinical study of FDA data

Summary:

Hepatitis acute is reported as a side effect among people who take Cimzia (certolizumab pegol), especially for people who are female, 20-29 old, have been taking the drug for 1 - 6 months also take Prednisone, and have Juvenile rheumatoid arthritis.

The phase IV clinical study analyzes which people have Hepatitis acute when taking Cimzia. It is created by eHealthMe based on reports of 106,367 people who have side effects when taking Cimzia from the FDA, and is updated regularly.

What is Cimzia?

Cimzia has active ingredients of certolizumab pegol. It is often used in rheumatoid arthritis. eHealthMe is studying from 106,745 Cimzia users. Check the latest studies of Cimzia.

What is Hepatitis acute?

Hepatitis acute is found to be associated with 598 drugs and 877 conditions by eHealthMe. Check the latest studies of Hepatitis acute.

On Jul, 25, 2026

106,367 people reported to have side effects when taking Cimzia.
Among them, 11 people (0.01%) have Hepatitis acute.

Among these 11 people:

How long have people been on Cimzia when they have Hepatitis acute? *

What is the gender of people who have Hepatitis acute when taking Cimzia? *

female: 80 %
male: 20 %

What is the age of people who have Hepatitis acute when taking Cimzia? *

What are other drugs people take besides Cimzia? *

What are other side effects people have besides Hepatitis acute? *

Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 5 people, 45.45%
Acute Hepatic Failure: 5 people, 45.45%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 9.09%
Migraine (headache): 1 person, 9.09%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 1 person, 9.09%
Itching: 1 person, 9.09%
Hepatitis C Antibody Positive: 1 person, 9.09%
Hepatic Steatosis (fatty liver disease): 1 person, 9.09%
Gallstones (stone formation by bile component): 1 person, 9.09%
Faeces Discolored: 1 person, 9.09%

What are the existing conditions these people have? *

Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 5 people, 45.45%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cimzia and have Hepatitis acute?

- Check whether Hepatitis acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cimzia:

Cimzia (106,745 reports)

Hepatitis acute treatments and more:

Hepatitis acute (7,695 reports)

Browse all side effects of Cimzia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis acute:

Hepatitis acute (598 drugs)

Browse all the conditions that are associated with Hepatitis acute:

Hepatitis acute (877 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on certolizumab pegol (the active ingredients of Cimzia) and Cimzia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.